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  What are the barriers to the SHAI being completed within a CFS/ME service? 
Abstract  
Background: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a 
debilitating condition, characterised by unexplained and excessive fatigue, muscle pain and 
sleep disturbances. Health anxiety is common in CFS/ME and accurate measurement is 
essential in facilitating therapeutic gains. However, there are clinical concerns over the utility 
of  the Short Health Anxiety Inventory (SHAI) in measuring health anxiety in this population. 
Aims: This study aims to use qualitative responses from two ex-service users and specialist 
health clinicians to explore the barriers to completing the SHAI within a specialist CFS/ME 
service. Method: Qualitative responses from a focus group comprising of 15 specialist health 
professionals including occupational therapists, physiotherapists, dieticians, cognitive 
behavioural therapists, counsellors, clinical psychologists and assistant psychologists were 
transcribed and analysed for themes. Patient voices were represented by two former service 
users through individual semi-structured interviews on the telephone, which were recorded, 
transcribed and later analysed thematically.  Results: Clinicians and service user involvement 
agreed on core difficulties with the utility of the SHAI in the CFS/ME population. The timing 
of the SHAI being administered pre-diagnosis, the language of the SHAI and lack of context 
around the questionnaire were identified as barriers that were likely to be contributing to the 
SHAI not being completed by service users. Conclusion: Sensitive and accurate 
measurement is required in order to retain patient engagement, which could further facilitate 
appropriate assessment and treatment of health anxiety and CFS/ME. As such, findings 
suggest that adaption of the SHAI is vital for use with CFS/ME. 
Key words: CFS/ME, chronic fatigue, CBT, health anxiety, fatigue syndrome 
Key Learning Aims: 
• Understanding the different barriers to completing the SHAI in a CFS/ME Service 
• Understanding the implications of administering the SHAI to CFS/ME Service Users 
• Learning from multi-disciplinary CFS/ME health professionals about perceived 
difficulties in administering the SHAI 
 
Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) is a debilitating condition 
that contributes to lower quality of life and is characterised by unexplained, ongoing and 
excessive fatigue that is not alleviated by rest (NICE, 2007). Other common symptoms 
include joint pain, sleep disturbances and cognitive difficulties (NICE, 2007). Prevalence 
rates are estimated at 0.17-2.07% and depression and comorbid anxiety disorders are 
common (Johnston, Brenu, Staines, & Marshall-Gradisnik, 2013; Cella, White, Sharpe, & 
Chalder, 2013). This is reflected in the great economic impact of CFS/ME on employment 
and productivity in the United Kingdom, that is estimated to be over £102 million a year 
(Collin, Crawley, May, Sterne & Hollingworth, 2011).  However, the aetiology of CFS/ME 
remains poorly understood. 
It has been reported that health anxiety is common in those living with CFS/ME 
(Daniels, Brigden, & Kacorova, 2017). Health anxiety is characterised by a preoccupation 
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with health concerns and misinterpretation of bodily sensations as more threatening and 
serious than they actually are (Abramowitz, Olatunji, & Deacon 2007).  Daniels et al. (2017) 
suggest that patients with CFS/ME may be more predisposed to developing health anxiety 
due to the complex and heterogeneous nature of the condition; CFS/ME bears a significant 
physical impact and a range of worrying symptoms. When considering the heterogeneity, 
uncertain prognosis, lack of understanding and confidence among health professionals 
(Daniels, Parker and Salkovskis, 20200 it seems logical that patients with this condition 
worry about their health. Health anxiety in those with CFS/ME has been found to be 
significantly higher than that of other medical conditions and similar to the levels found in 
chronic pain (Daniels et al., 2020); two studies have reported rates of around 42% in clinical 
samples (Daniels et al. 2017; Daniels et al 2020).  
Health anxiety is a relatively new concept to be explored within the field of CFS/ME. 
Yet, pragmatic evidence from case studies suggests that treatment using a CBT-based health 
anxiety model can benefit those with CFS/ME who are health anxious, both in terms of their 
physical and mental health (Daniels & Loades, 2016; Daniels et al., 2020).  Daniels & Loades 
(2016) suggest that there is a high degree of overlap between the symptomatic presentation, 
and by targeting overlapping characteristics, there is likely to be benefit to both conditions.  
Current NICE guidelines recommend treating associated comorbid anxiety, 
depression or mood disorders in individuals with CFS/ME (NICE, 2007). However, only 
small to moderate improvements in functional impairment, anxiety, depression and fatigue 
have been found following CBT interventions (Castell, Kazantzis, & Moss‐Morris, 2011). 
Large effect sizes were reported by Daniels et al. (2020), however this was a small 
uncontrolled sample and specifically targeted health anxiety, despite also seeing treatment 
effects for anxiety and depression. Based on data from replicated studies, health anxiety is 
common in CFS/ME and is associated with higher symptom severity and elevated 
psychological distress (Daniels, Parker and Salkovskis, 2020).  It is therefore essential that 
health anxiety is identified and treated.  
The Short Health Anxiety Inventory (SHAI; Salkovskis et al., 2002) is a short form 
measure designed to screen for clinical levels of health anxiety. It is derived from the clinical 
cognitive behavioural model of health anxiety and is frequently used in clinical practice and 
in intervention and epidemiological literature (Alberts, Hadjistavropoulos, Jones, & Sharpe, 
2013). The SHAI has been found to be reliable for use in CFS/ME (Daniels et al. 2017; 
Daniels et al. 2010); however, there are clinical and practical concerns of its acceptability and 
accessibility to those with CFS/ME. Earlier research has indicated negative views towards the 
HAI on the part of the clinician (Daniels, Parker and Salkovskis, 2020) which has influenced 
recruitment to a treatment trial for ME/CFS, and also more directly the patient, where it has 
been suggested that the content and phrasing of the questionnaire is inflammatory resulting in 
non-completion. Daniels et al., (2020) reported that a proportion of clinicians and patients 
expressed scepticism over the SHAI, although this was not formally captured. It was reported 
that this may have influenced recruitment to the treatment trial; scepticism relating to the 
SHAI may have subjected recruitment to selective bias from clinicians with positive/neutral 
views of the SHAI, leaving opportunity for inadvertent sampling bias of psychologically 
receptive participants only (Daniels, Parker & Salkovskis, 2020). Such concerns indicate that 
there may be key barriers to the assessment and treatment of CFS/ME due to characteristics 
associated with the SHAI.  The aim of this study was to explore in more detail the potential 
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barriers to the SHAI being completed within a specialist CFS/ME clinic, using qualitative 
responses from a range of CFS/ME clinicians and service user involvement in order make 
recommendations for future use and development of the SHAI.  
Methods 
Design and setting  
This study adopted a qualitative design, using a focus group approach, and individual 
telephone interviews to generate themes pertaining to the study aims.   
Participants  
The service  
The CFS/ME service from which the sample was taken in the present study comprised of 
multi-disciplinary specialist health professionals, including occupational therapists, 
physiotherapists, dieticians, cognitive behavioural therapists, counsellors, clinical 
psychologists and assistant psychologists. The service delivers a range of evidence-based 
interventions in individual and group formats.   
Following a referral into the service, patients are sent an appointment letter and several 
questionnaires to complete ahead of their assessment. The Health Anxiety Inventory (SHAI; 
Salkovskis, Rimes, Warwick & Clark, 2002) formed part of the pre-assessment 
questionnaires, alongside other questionnaires from the UK CFS/ME National Outcomes 
Database.  
Former Service Users 
Two former service users who had received treatment at the specialist CFS/ME service were 
recruited to participate in the study. One former service-user was already associated with the 
broader programme of research (see Daniels et al., 2020) in a public and patient involvement 
(PPI) role, the other was a service-user identified by the CFS service who regularly advised in 
a PPI related role. 
Measures 
Short Health Anxiety Inventory (SHAI; Salkovskis et al., 2002) 
The SHAI is an 18-item questionnaire that measures cognitive factors associated with health 
anxiety on a four-point scale. The 18-item measure is a short-form of the original health 
anxiety inventory (Salkovskis et al., 2002). Items assess awareness of bodily sensations, 
worries over health and feelings of fear associated with having an illness and are summed to 
produce a total score, with a cut off of >18 to indicate clinical levels of distress. The SHAI 
has demonstrated good reliability and validity across samples with pain, long-term health 
conditions (Alberts et al., 2013) and CFS/ME (Daniels et al. 2017; Daniels et al., 2020.) 
 
Procedure 
Focus Group Discussion with CFS/ME Clinicians 
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Fifteen clinicians (four occupational therapists, three physiotherapists, four clinical 
psychologists, a dietician, assistant psychologist, a cognitive behavioural therapist and 
counsellor) from the CFS/ME service participated in an hour-long discussion about their 
experiences of using the SHAI using semi-structured questions related to (a) how the SHAI 
was used in the service and (b) what, if any, barriers were perceived to completing the 
measure. All clinicians who were invited to the focus group participated. The discussion was 
very inclusive, all members of the focus group contributed on more than one occasion and the 
conversation was very fluid and cooperative. The discussion was audio recorded and later 
transcribed. 
Telephone Consultations with Former Service Users 
For this study, the patient voice was represented by two former service users. They were 
interviewed individually over the telephone for 30-45 minutes. During this call, the SHAI 
was discussed line by line and participants were consulted on their views on why the SHAI 
was not being completed and what could be getting in the way. The telephone call was audio 
recorded, transcribed and later analysed. 
 
Analysis 
Focus Group with CFS/ME Clinicians 
Once transcribed, the data was analysed using Braun & Clarke (2006)’s six phases of 
analysis. Data was initially coded, with themes then drawn and reviewed. Initial codes were 
generated by systematically coding interesting features throughout the transcripts.  Codes 
were then gathered into potential themes and reviewed across the entire data set. Themes 
were reviewed by the authors, refining the specifics of each theme to generate clear 
definitions and names. Inter-rater reliability was not calculated.  The themes were defined 
and named and weaved together to offer a narrative of the emerging themes from the focus 
group.  
Telephone Consultations with Former Service Users 
Themes emerging from the telephone calls with two former service users were further 
transcribed analysed using thematic analysis (Braun & Clarke, 2006). A similar process of 
coding, reviewing and refining was followed as above. Care was taken to not simply fit the 
data into pre-existing codes. 
  
Results 
Results from the focus group with 15 clinicians from the specialist CFS/ME service are 
discussed below; results from telephone consultations with former service users are discussed 
thereafter. 
Results from Clinician Focus Group 
Discussion over the use and barriers to completion of the SHAI produced salient themes 
relating to timing, phrasing and language, demand characteristics and response bias, context 
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and negative past experiences.  An item-by-item breakdown of pertinent comments relating 
the SHAI can be found in Table 1 (supplemented).  
Timing 
The theme of the timing of administration of the SHAI as a barrier to its completion was 
highlighted by clinicians. In particular, early administration was thought to hamper patient 
engagement. For example, it was suggested that if the SHAI is given to patients before they 
have had the opportunity to discuss their CFS/ME symptoms, it may lead to them 
misinterpreting the purpose of the SHAI. There was a sense of agreement that it would be 
helpful to screen for health anxiety among patients in the service, but not at the point of 
assessment. This is reflected in the quote below: 
“People have just not understood how to answer these because people often don’t 
have a diagnosis so they have been going to their GP for all these unexplained 
symptoms and naturally you’re going to be worried about what is wrong with you, 
you want to find out what is wrong with you.  So there’s something odd about that, 
how you apply those questions at that time as well, when a diagnosis isn’t known 
yet.” 
Clinicians expressed concerns that administering the SHAI as part of the assessment 
may skew patients’ interpretations of the questions and consequent responses. One 
clinician felt the scores on the SHAI were “skewed by the fact that they are coming 
into a service”, because when patients go to an assessment, “thoughts are going to be 
around their health.” In this sense, at first point of access, patients are already 
predisposed to thinking about their health. This may impair the validity and the 
specificity of the SHAI, as scores may be inflated by the process of being referred to a 
specialist service It became apparent through discussion that the completion of the 
SHAI would possess more meaning to the patient post-diagnosis of CFS/ME“I think 
down the line with people there is value in identifying those people who are constantly 
symptom-focussing, I think that’s kind of important, but not at the point of assessment, 
perhaps that’s not the best stage?” 
Taken together, analyses suggest that early administration of the SHAI may 
negatively influence patients’ perception of and responses to the SHAI. 
Context 
The theme of context arose as an important factor to consider when using the SHAI with 
regard to the context in which the SHAI is administered and also the context of CFS/ME 
within wider society. One clinician queried the use of the SHAI and its complex placement in 
the CFS/ME population. Particular concerns were shared in how best to legitimise patients’ 
experiences whilst assessing for health anxiety. Clinicians shared fears that the SHAI may not 
be fully understood by patients and that this may unintentionally reinforce messages about 
the credibility of their symptoms associated with CFS/ME.  
 “I think that there is a particular culture around CFS/ME, more so than other health 
conditions around whether this is real.  That is a real theme in our patient group and 
outpatient clinics.” 
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Clinicians reported that as part of their clinical practice, clearly explaining the 
rationale behind the SHAI was imperative to ease patients’ concerns and maintain 
engagement. Communicating to patients the purpose of the SHAI as an explorative tool was 
seen as important in order to engage patients: 
 “often I’ve done a bit of work about ‘yes it is separate to the other forms’ and putting 
it in the context of ‘we are learning a lot about psychological help for people with all 
sorts of conditions like, cancer, Parkinson’s, MS, so, we’re exploring’, just trying to 
provide a bit more context within a wider medical background.”  
 Clinicians agreed that without this explanation, patients may respond negatively to 
the SHAI, becoming self-blaming or feeling as though they were being perceived by 
clinicians a hypochondriac or that they were exaggerating their difficulties somehow.. 
Without appropriate context given, patients may feel that the SHAI trivialises aspects of their 
condition or discredits concerns that patients may have about their physical health. Clinicians 
shared a sense of responsibility to reassure patients in order to buffer against any potential 
stigmatisation that may be implicit in the SHAI: 
“patients could think ‘it’s all in my mind’ especially if the question, the individual 
questions reinforce that.”   
“Look, all we really need to say to people is ‘we know you’re ill – do you think you 
worry about it too much?’ That’s really what we’re saying isn’t it?  People can 
understand that!” 
Therefore, a desire for a more transparent and simplified way of measuring health 
anxiety and illness-related worry, without rupturing rapport, was desired by clinical staff: 
“when you finally find a place that you feel trusted and that you can trust and that 
you can believe and you find you finally feel like you’re getting somewhere, to 
suddenly have this, this questionnaire, it’s a little bit like a slap in the face.  I feel it is 
quite…strongly worded as to make them think, yeah, their illness it’s saying that their 
illness might be in their mind, and that we actually maybe secretly do think that.” 
Some clinicians also doubted the appropriateness of using the SHAI with those with  
CFS/ME. Throughout, the uniqueness about the condition was emphasised, with clinicians 
commenting on the differences between health anxiety in general, and health anxiety in those 
with CFS/ME. This is reflected in the quote below: 
“I think also there’s, whether this is capturing people’s anxiety in the way it presents 
in this cohort of people.  I think the construct is different, being anxious about your 
health in the context of having a health condition compared to not, I think this isn’t 
the best tool to do it.” 
Negative Past experiences 
Numerous clinicians mentioned the contentious culture surrounding CFS/ME and commented 
on the need to consider the SHAI in the context of  negative past experiences that CFS/ME 
patients may have endured. Words such as “confrontation,” and “fight” articulate a sense of 
opposition and defiance in patients: 
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“It depends on what their experience of having the illness is and the messages that 
they’ve been told, that they’ve been trying to fight against and if that’s not been good, 
to be suddenly confronted with something like this could be incredibly, well, it could 
be enough to make someone walk out I’d have thought.” 
Clinicians commented that due to the public treatment of CFS/ME, a measure that 
lacks sensitivity and appears confrontational may be viewed as unacceptable or inappropriate 
to use for those with CFS/ME. Clinicians shared concerns that some of the items and 
concepts raised in the SHAI were directly incongruent with how patients viewed themselves 
and their illness; causing them to feel as though their symptoms and feelings were not being 
validated through the SHAI: 
“Yeah, and I think the legitimacy issue, it just, is actually probably very different to a 
lot of other conditions.” 
 Clinicians shared concerns that the use of the SHAI may lead to patients disengaging 
with the measure and with the service generally, given that some patients may not have 
previously been believed or faced stigma in their help-seeking journey. With 
acknowledgement of this, it was evident that psychosocial factors that were beyond the 
control of the service, could directly affect service use because of the SHAI.  
 “I think we really take a lot of stuff about people’s journeys totally for granted and 
the jargon that people are suddenly faced with, as, you know, even with all the other 
forms, let alone this.   
Taken together, there was a shared appreciation that the CFS/ME population may be 
unique in their experiences of gaining help for their illness, and associated measures used at 
assessments may be sensitive to this. Concerns were mostly raised that the SHAI is not 
suitable for use with those with CFS/ME, due to some items being perceived as 
confrontational, echoing previous negative experiences of deligitimisation.   
Phrasing and Language 
The theme of phrasing and language used in the SHAI was identified as a key barrier to 
completion. Clinicians were in agreement over the inaccessibility of the SHAI, in terms of the 
medical language used and its lengthy appearance. There were concerns that this could cause 
difficulties with patients accurately understanding and responding to the questionnaire. There 
was also agreement that there were elements of repition within the SHAI.  Clinicians shared 
concerns that the questionnaire was “pitched too high” as “each line is very wordy” and not 
accessible to non-medical audiences.   
 “in terms of readability…that looks really high on a reading scale for most patients.”   
Given that the SHAI is typically issued amongst a battery of other questionnaires, 
within in CFS/ME service, clinicians suggested that the poor readability of the questionnaire, 
nestled amongst other measures may be overwhelming for service users. Given that 
completion fatigue is a common issue in the general population, this may be exacerbated in 
those with CFS/ME, who may struggle to a greater degree with concentration and energy 
difficulties. The demands of completing a measure laden with emotive items, in combination 
with complex language, may lead to a reluctance to complete the SHAI. This is demonstrated 
in the quotes below: 
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“By the time they’ve got through the rest of the form, they’ve probably run out of 
energy and steam and mental ability and concentration to be able to cope with it and 
then they look at the words and just think ‘whoa, I can’t do it’.” 
“So just reading them out, I thought if I had to fill that in I’d find it more of a 
challenge.  When you’re struggling with a lot of brain fog…I can see where people 
would struggle, just physically reading it, let alone the sort of thought process that it 
takes you down.” 
The SHAI’s focus on physical symptoms was also thought to hinder patient 
engagement and endorsement of specific items. Clinicians agreed that some of the phrasing 
of the language in the SHAI  were potentially inappropriate and unacceptable to those with 
CFS/ME: that the principles of the SHAI may not generalise to those experiencing physical 
health problems. There were also concerns that patients may misunderstand the aim of the 
questions due to the medical focus on physical sensations. Some items were considered to be 
subjective and therefore more likely to be endorsed in those experiencing physical 
complaints. For example, one clinician stated: 
“I wonder with the specific items, the wording of it, how many things you might 
endorse, just because you’ve got a health problem with multiple symptoms.”   
. Some items in the SHAI were also thought to be at odds with the experience of 
individuals with CFS/MEClinicians stated that those with CFS/ME may feel that they are ill 
and very unwell, and perceive that the authenticity of their illness is being questioned through 
the SHAI. This may lead to feelings of rejection or belittlement, as illustrated in the below 
quote:  
 “They feel ill, their felt experience is that they are very poorly so the idea that their 
GP telling them there is nothing wrong is never in a million years going to be 
reassuring.”  
In particular, there were strong opinions about the phrasing of individual items of the 
SHAI, pertaining to phrases such as ‘serious illness’, ‘bodily sensations’, ‘lastingly relieved’ 
and ‘worry’: 
“well ‘lastingly relieved if my doctor tells me there is nothing wrong’, you know, it’s 
like you want them to find the thing that’s wrong with you from all these 
investigations, so that’s going to skew that answer as well… I’m not going to be 
relieved if my doctor tells me there is nothing wrong because I’m still ill, that’s why 
I’m here!” 
Indeed, several clinicians expressed reservations about the appropriateness of using 
the SHAI in the service in general. 
Demand characteristics and response bias 
The issue of demand characteristics and response bias to the SHAI was highlighted by the 
group. Clinicians shared concerns that patients may possibly feel the need to emphasise their 
symptoms to gain a CFS/ME diagnosis and be ‘believed’. In this sense, service users may 
respond with social desirability, utilising the measure as a tool to gain additional help from 
clinicians. One clinician stated,  
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“I wonder if there might be an element of wanting to feel in a quite extreme way to 
prove that they are struggling, as a diagnostic almost?” 
“I think people are thinking what are we thinking…they see these boxes and they 
think that they are helping us by providing false information.”  
In contrast, clinicians also expressed concerns that CFS/ME patients may answer 
questions with a sense of preserved caution. Clinicians perceived that patients may be fearful 
of being misunderstood or believed by health professionals, depending on their responses to 
the SHAI. Specifically, clinicians perceived a sense of fear of being blamed, not believed, or 
told “it is all in my head,” during the completion of the SHAI. Words such as “guarded,” and 
“resistance,” were used by clinicians, conveying a sense of defensiveness and unease from 
patients. One clinician stated: 
“Giving somebody a questionnaire working in CFS/ME, I can imagine, there could be 
some resistance to it and people being quite guarded around what information they 
are giving you and if this will go as part of their diagnosis then they might be quite 
guarded about how they might achieve that.  There could be, for some people, well 
not everybody but, could be some resistance to answering that or disclosing 
information.” 
This perceived sense of guardedness, reluctance and apprehension for fear of being 
misunderstood or misdiagnosed was seen as a barrier to completing the SHAI.  This led to  
clinicians contemplating whether further training in delivering the SHAI in a CFS/ME service 
was required: 
“maybe we’re not couching it enough in terms of actually, like with other conditions 
you can have like anxiety as well as other conditions, maybe we’re not doing enough 
around that because then it becomes either it’s this or it’s CFS.” 
 There was an agreed sense that the SHAI did not fully capture the multifaceted 
nature of health anxiety within the CFS/ME population, with the SHAI lacking sensitivity 
to how features of anxiety is uniquely manifested through living with an illness with no 
unified cause, whilst also acknowledging features of health anxiety that are in themselves 
debilitating and common to other medical diagnoses. 
Results from Telephone Consultations with Former Service Users 
Two former-service users (Participant 1 and Participant 2) were consulted via telephone for 
their views on why the SHAI wasn’t being completed and what may be perceived barriers to 
its completion. An item-by-item breakdown of pertinent comments relating to the SHAI can 
be found in Table 2 (supplemented). 
Main themes that emerged from discussions with participants were similar to that of 
the clinician focus group, but were narrower in focus: Timing, Context and Phrasing and 
Language. Although participants reported similar views on the timing and context of the 
administration of the SHAI as barriers to completion, there were differences in opinion on 
some items of the SHAI. 
Timing  
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There was agreement amongst participants that it would be helpful to think about the timing 
of administering the SHAI. Administering the SHAI before diagnosis was seen as confusing 
and left a sense of ambiguity around the purpose of the SHAI. More specifically, 
administering the SHAI pre-diagnosis led to some items on the SHAI being difficult to 
answer, with terms mentioned being perceived as conditional or not applicable at that stage. 
“A lot of questions are tapping into what I as someone living with CFS experience on 
a daily basis. You’re giving the questionnaire at a point when you are trying to assess 
people who don’t have the diagnosis yet and so they could feel confused by the term 
serious illness.” 
As reflected in the quote below, participants warned that the timing of the SHAI was 
crucial in facilitating rapport and engagement. There was some acknowledgement that the 
point of administration of the SHAI interacts with the individual’s symptomatic and 
diagnostic journey. Phrases such as ‘in their face’ suggests that pre-diagnosis, the use of the 
SHAI may be confrontational, provocative or ‘against’ patients. 
“Perhaps it is about timing? If people are diagnosed already, they might be more 
open. If people are really bad with symptoms, it can be in their face.” 
Context 
Participants agreed that setting the context of the SHAI was important to aid its completion. 
One participant suggested that an introductory sentiment was needed to ‘soften’ the use of the 
SHAI. It was expressed that this would make the SHAI seem more warranted and be greeted 
with less perceived stigma. This could potentially cushion any negative perceptions of the 
‘bluntness’ of the language used in the SHAI. Without this, participants cautioned that 
patients may perceive a sense of judgement from clinicians when using the measure. 
“The statements and language are so dry and very direct. I wonder if an introduction 
would help put people’s minds in a different mindset? It’s very blunt! So like, ‘This 
type of questionnaire is generally used in the medical profession and not just 
CFS/ME, it applies to other conditions…’” 
Both individuals suggested recommendations to overcome the barriers they identified, 
including providing an introduction to give context and to distinguish the use of the SHAI as 
being a measurement of health anxiety, and not in relation to CFS/ME symptoms. 
 “If they said, ‘We are not trying to judge. This is a questionnaire used in other 
services and is part of the whole package to treat you better.’” 
Participants emphasised that it would be helpful if the holistic treatment of CFS/ME 
was communicated when administering the SHAI, as mentioned in treating ‘the whole 
package’ in the above quote. It could be inferred that for some patients on their diagnostic 
journey, there may be a misunderstanding or unawareness of the role of health anxiety in 
CFS/ME. Through explaining the use of the SHAI and emphasising holistic benefits of 
completing the measure, clinicians could enable openness and instil hope in patients 
completing the SHAI. 
Phrasing and Language 
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Both Participant 1 and Participant 2 felt there were issues with some of the language used in 
the SHAI. Concerns were raised over language being outdated or too technical (e.g. 
‘hypochondriac’).  
Participants queried what whether other patients would be able to understand a 
number of the words used in the SHAI such as ‘bodily sensations’, ‘ill’, ‘images’, ‘serious 
illness’, and ‘lastingly relieved.’ These misgivings over the language were particularly salient 
in reference to the context of CFS/ME and its surrounding social context. 
“Lastingly relieved is a strange use of words. If you feel ill and the GP says nothing is 
wrong, I’m not relieved but angry.” 
Participants also described difficulties answering item two (e.g. “I notice aches/pains 
less than most other people my age”) and fourteen (e.g. “My friends and family would say I 
worry too much about my health”) of the SHAI. Both individuals struggled to be sure of 
“what people think.” These responses may reflect isolation from other people their age or a 
tendency to focus attention on one’s own experience, rather than noticing what others are 
experiencing in the world around them.    
 “How do I know what other people are experiencing…a six to me may be a two to 
you…I have no idea how much pain others may be going through!” 
However, Participant 1 and Participant 2’s views differed on a number of other items 
(including items six to ten and item thirteen), capturing the variety of responses that can be 
generated after completing the SHAI.  Contrasting comments included “I didn’t have a 
problem with that one”, “I think it is fine” and “I don’t have a problem with it” for items 
eight, ten and thirteen.  Whilst Participant 2 did not have a problem with item nine (e.g “If I 
hear about an illness I never think I have it myself.”), they stated: 
“If people with CFS/ME are not given a diagnosis you do listen to illnesses and 
wonder if that is what is wrong with you.  I tried to make sense of what I was 
experiencing as no one was making sense of it for me.  It is a natural thing to do 
before receiving a diagnosis.  You look at your symptoms and think is that what is 
happening to me?” 
There was concern that many of the items on the SHAI held negative connotations 
and both Participant 1 and Participant 2 reported experiencing strong emotions in response to 
some of the items. The language used in some items of the SHAI held a perceived stigma 
towards patients’ strength and ability to cope with symptoms. Words used in the SHAI such 
as ‘resist’ or ‘afraid’ may be seen to locate the responsibility and blame of the distress within 
the individual with CFS/ME. There was a sense that some of the language used in the SHAI 
implies a specific weakness within the individual, which contrasts against societal 
expectations of being ‘strong’: 
“Worry implying weakness in a society where stiff upper lip prevails.” 
“Resisting thoughts seems a bit clumsy and suggests a battle… It insinuates that I am 
weak in character because I can’t resist them and that a resilient person would be 
able to.”  
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“The verb ‘afraid’ insinuates you could be weak or get scared. Strong people don’t 
get scared.” 
As shown in the quotes above, participants often compared implications of strength 
and resilience, with weakness and fear. There was a sense that the SHAI dichotomised or 
categorised respondents’ efforts to manage their symptoms. Overall, participants expressed 
that the language used in the SHAI was experienced at times as invalidating, stigmatising or 
disapproving. 
 
Discussion 
This study aimed to understand the barriers to the Short Health Anxiety Inventory (SHAI; 
Salkovskis et al., 2002) being completed within a specialist CFS/ME service. This was to 
give insight into the ways in which this may be overcome, rather than bear impact on 
assessment and treatment of health anxiety, a commonly presenting problem in CFS/ME.  
Overall, the themes generated in this study indicate that adaptation of the SHAI is critical for 
its use with those with CFS/ME.  Concerns raised suggest that the SHAI measure is 
unacceptable to service-users due to the wording and language used, and that this (a) impacts 
clinicians’ ability to engage and develop a therapeutic relationship and (b) potentially leads to 
neglect of a pressing clinical need. Research into the socialisation to the model in CFS/ME 
(Daniels & Wearden, 2011) indicate that holding a shared understanding of the presenting 
problem is an active component in the therapeutic alliance, supporting clinicians’ views. In 
addition, such research supports the notion that if questions on the SHAI give the impression 
that health anxiety, rather than CFS/ME is the problem, or rather that it is a mental health 
problem rather than a physical health problem, this is likely to undermine a shared 
understanding and lead to disengagement. This not only risks impacting the treatment of 
health anxiety, but treatment of CFS/ME also.  
Based on the findings of this study, it is recommended that CFS/ME services or those 
which offer treatment for CFS/ME, should carefully consider the timing of the administration 
of the SHAI as well as the wider cultural context of CFS/ME. It can be inferred that the 
administration of the SHAI upon initial consultation may provide a barrier to engagement for 
service users, altering their perceptions of the role of the service, expected diagnoses and 
resultant treatment as result. Without acknowledging the broader sociocultural context 
surrounding CFS/ME, a perceived sense of stigma presents as a barrier to the completion of 
the SHAI. 
 Previous studies have shown that those with with CFS have experienced 
stigmatisation before receiving a formal diagnosis (Åsbring & Närvänen, 2012; Vodel, Wade 
& Haake, 2006) and perceived stigma and self-stigma has been known to affect psychological 
help seeking and engagement (Vogel, Wade & Haake, 2006;Varni, Miller, McCuin & 
Solomon, 2012). Theoretically, this may be because health-focused anxiety is intensified or 
elicited to greater extents when other social-cultural factors exist, such as the stigmatisation 
reported in CFS/ME (Daniels et al., 2020; Dickson, Knussen & Flowers, 2007). Indeed, Stoll 
et al., (2017) suggest that the inability to fully explain the symptoms in CFS/ME and the 
medical uncertainty around the diagnosis is linked with increased prevalence rates of anxiety 
in such groups. Withdrawing from with others and withholding information is a common 
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tactic in reducing stigma (Åsbring & Närvänen, 2012). Therefore, legitimising patient 
concerns and maintaining rapport remains an important feature of service engagement and 
therapeutic alliance (Daniels & Warden, 2011). It is likely that the measure requires 
adaptation to achieve acceptability with a population whose primary physical illness has not 
as yet identified cause, and when stigma surrounding a condition may present as a barrier to 
engagement.  
It is noted that the SHAI originated from a need to sensitively measure health anxiety 
in medical contexts, without the elevation of scores through compounding concerns relating 
to the belief that one is physically ill (Salkovskis et al., 2002). Despite the measure 
possessing proved utility, with good reliability in medical clinics and CFS/ME groups( α = 
.89) (Daniels et al., 2017) and its use in evaluating health anxiety outcomes from CBT-based 
interventions for those with CFS/ME (Daniels et al., 2020), it is evident that incompatibilities 
exist given the unique difficulties facing this population. If it is not acceptable and valid to 
the clinician, its use is limited.  
Strengths and Limitations 
A strength of the current study is the clinical relevance and ecological validity for health 
practitioners and patients with CFS/ME which underpins this study. Clinician’s verbatim 
quotes provided rich qualitative data which can be used as a foundation for the development 
and adaptation of the SHAI. As a range of CFS/ME health practitioners were consulted, this 
increases the applicability of findings and reflects experiences from different specialist 
viewpoints. There was a good degree of cohesion within the group conversation and equal 
representation of different professionals within the group. Whilst it is noted that clinician 
views were explored in a group-setting and former service-users were consulted individually, 
individual interviews were used for the comfort of participants: to protect their anonymity 
and to create a safe space to explore freely. We acknowledge that individual staff interviews 
may have provided richer data, although this was a resource limitation in the current study. 
This study has identified a range of barriers to completing the SHAI within CFS/ME, an area 
that has not previously been explored in depth. As there has also been a call for treatments 
that specifically target anxiety in CFS/ME (Stoll et al., 2017), it is hoped this study adds to 
the dearth of literature in this area to promote appropriate assessment and treatment of health 
anxiety in CFS/ME services, allowing for the clinical needs of patients to be met. 
Although former service users were interviewed as part of this study, a limitation of 
this study is that current patients within the service were not consulted regarding their 
experiences of completing the SHAI, however this work is underway. We also note that there 
the clinician voice is overrepresented in this study as fewer service users were consulted over 
their views of the SHAI.  However due to service-level limitations, we were unable to consult 
more patients within the service. Whilst there was a clear consensus within the group 
interview with clinicians over the barriers of the SHAI in this exploratory study, further 
investigation is required to establish the generalisability of such viewpoints and comments 
amongst clinicians.  
Additional research should therefore provide a more robust representation of service 
users and patient experiences and offer in-depth individual clinician consultations in order to 
provide richer data, contingent on resource availability. Due to the nature of the measure we 
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were unable to differentiate fears relating ME/CFS or fears relating to contracting an 
additional medical condition such as Cancer, MS and so forth. Future development of the 
SHAI should aim to more closely specify whether illness related fears are associated with an 
existing condition or otherwise. This work is currently on going. 
 
Implications 
Administering the SHAI at the end of the assessment appointment would allow for 
additional context to be provided by the assessing clinician for those accessing CFS/ME 
services; this would provide an opportunity to acknowledge that although it is normal to 
worry about one’s health, particularly during the process of investigation and repeated 
assessment, for some, this worry can become a preoccupation which can be distressing. 
Providing information about the purpose of the questionnaire could also improve its 
completion. For example, an introductory paragraph could be included to support the 
rationale for use (i.e. prevalence of health anxiety in CFS/ME), which may then also 
normalise the experience. Given that health anxiety is significantly more prominent in those 
with CFS/ME (Daniels et al., 2020), the specific sociocultural backdrop of this condition 
should also be considered when using standard measures, such as the SHAI to aid its 
completion.   
In terms of the SHAI itself, adaptations could be made to make it more suitable for 
use with those with CFS/ME, such as the adaptation of language and phraseology. Kehler and 
Hadjistavropoulos (2008) validated the SHAI within the Multiple Sclerosis (MS) populations 
and found that adding “other than MS” to items five, nine, eleven and twelve of the SHAI 
improved its acceptability. In this way, participant’s responses were not limited by having a 
serious health condition. A study using qualitative feedback from children with CFS/ME 
found that inclusion of words relating to specific symptoms associated with CFS/ME 
increased engagement and acceptability of standard interview methods (Parslow, Shaw, 
Haywood & Crawley, 2019). For example, contextualising the impact of CFS/ME on 
functioning and interference with completing activities, in terms of ‘payback,’ was reported 
as a helpful framing method, because it related to a unique feature of CFS/ME (Parslow et al., 
2019).  
Given the expanding evidence base in relation to interventions for CFS/ME in recent 
years, there is a paralleled need for the accurate and acceptable measurement of typical 
outcomes associated with CFS/ME, such as health anxiety (Alberts et al., 2013). Considering 
that treatment success is dependent upon accurate identification of presenting problems, there 
is a great need for a reliable and suitable measure, both clinically and in research (Caswell & 
Daniels, 2018). Accurate identification of presenting problems is further compromised in 
cases where comorbidity is high, such as those with CFS/ME (Daniels et al., 2020). Recent 
evidence further indicates that anxiety may interfere with therapeutic outcomes and is 
associated with greater symptom severity (Daniels et al., 2020). This supports the rationale 
for the development and adaption of the SHAI and other routine materials for the detection 
and treatment of co-morbid health anxiety.   
Sensitively addressing health anxiety within CBT interventions for CFS/ME may also 
improve therapeutic gains for service users with CFS/ME. The report ‘No decisions about 
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me, without me’ (ME Association, 2015) indicated that CBT was found to have a positive 
effect in aiding some patients to deal with comorbid issues, highlighting the importance of 
assessing patients with CFS/ME for such difficulties and ensuring they have access to 
treatment. However, a large meta-analysis showed only small to moderate improvements in 
functional impairment, anxiety, depression and fatigue are reported in standard CBT 
interventions for CFS/ME (Castell, Kazantzis, & Moss‐Morris, 2011). There are also 
disappointing differences between outcomes documented for CBT for CFS/ME in routine 
practice, compared with clinical trials, with levels of levels of anxiety, depression and fatigue 
in routine contexts failing to reduce to the extent as controlled trials (Fernie, Murphy, Wells, 
Nikčević, & Spada, 2016).  Sensitive measurement and treatment of (health) anxiety with 
CFS/ME may capitalise on therapeutic gains offered by CBT, when accurately measured, 
identified and treated (Daniels et al., 2020). 
Conclusion 
This study has identified a number of barriers to completing the SHAI within a CFS/ME 
service. Specialist clinicians and former servicers users alike shared common concerns 
relating to core difficulties with the utility of the SHAI in this population. The timing of the 
SHAI being administered pre-diagnosis, the language of the SHAI and lack of context around 
the questionnaire were identified as barriers to the SHAI not being completed by service-
users. Given the high co-morbidity of health anxiety in those with CFS/ME it is important 
that health anxiety is appropriately and sensitively measured in order to provide a better-
informed assessment, effective treatment and symptom relief for those with CFS/ME. 
Findings from this study suggest that adaptation of the SHAI is vital for use with CFS/ME 
and that further investigation of the measurement of health anxiety in this population is 
required.  
 
Key Practice Points: 
• The timing of the administration of the SHAI in the patient’s treatment pathway is an 
important factor to consider, especially when using the instrument at pre-diagnostic 
CFS/ME assessments. 
• Explaining the relationship between health anxiety and CFS/ME to patients at 
assessment may be important in aiding the completion and understanding of the SHAI 
and reducing service disengagement.  
•  Making efforts to explain potentially contentious language used in the SHAI may 
increase openness and connectivity in those with CFS/ME when assessing for health 
anxiety. 
• Sensitively measuring and addressing health anxiety within CFS/ME may offer 
greater treatment gains within CBT.  
 
Further Reading: 
Daniels, J., & Loades, M. E. (2016). A Novel Approach to Treating CFS and Co‐morbid 
Health Anxiety: A Case Study. Clinical Psychology & Psychotherapy. 
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Daniels, J., Brigden, A., & Kacorova, A. (2017). Anxiety and depression in chronic fatigue 
syndrome/myalgic encephalomyelitis (CFS/ME): examining the incidence of health 
anxiety in CFS/ME. Psychology and Psychotherapy: Theory, Research and Practice.  
Daniels, J., Parker, H., & Salkovskis, P. M. (2020). Prevalence and treatment of Chronic 
Fatigue Syndrome/Myalgic Encephalomyelitis and co-morbid severe health 
anxiety. International Journal of Clinical and Health Psychology, 20(1), 10-19. 
Tyrer, P., Salkovskis, P., Tyrer, H., Wang, D., Crawford, M. J., Dupont, S., ... & Bhogal, S. 
(2017). Cognitive–behaviour therapy for health anxiety in medical patients 
(CHAMP): a randomised controlled trial with outcomes to 5 years. Health 
Technology Assessment, 21(50), 1-58. 
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